A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer

被引：0
|
作者：
Pin Zhang
Binghe Xu
Lin Gui
Wenna Wang
Meng Xiu
Xiao Zhang
Guilan Sun
Xiaoyu Zhu
Jianjun Zou
机构：
[1] National Cancer Center/Cancer Hospital,
[2] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[3] Jiangsu Hengrui Medicine Co. Ltd,undefined
来源：
Biomarker Research | / 9卷
关键词：
Cyclin-dependent kinase 4/6 inhibitor; Advanced breast cancer; First-in-human trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effect of Cyclin-Dependent Kinase 4/6 Inhibitors on CirculatingCells in Patients with Metastatic Breast Cancer
    Lobo-Martins, Soraia
    Corredeira, Patricia
    Cavaco, Ana
    Rodrigues, Carolina
    Piairo, Paulina
    Lopes, Claudia
    Fraga, Joana
    Silva, Madalena
    Alves, Patricia
    Szeneszi, Lisiana Wachholz
    Barradas, Ana
    Duran, Camila Castro
    Antunes, Marilia
    Nogueira-Costa, Goncalo
    Sousa, Rita
    Pinto, Conceicao
    Ribeiro, Leonor
    Abreu, Catarina
    Torres, Sofia
    Quintela, Antonio
    Mata, Gadea
    Megias, Diego
    Ribot, Julie
    Serre, Karine
    Casimiro, Sandra
    Silva-Santos, Bruno
    Dieguez, Lorena
    Costa, Luis
    CELLS, 2024, 13 (16)
  • [22] Cyclin-Dependent Kinase 4/6 Inhibitors Combined With Radiotherapy for Patients With Metastatic Breast Cancer
    Ratosa, Ivica
    Orazem, Miha
    Scoccimarro, Erika
    Steinacher, Mateja
    Dominici, Luca
    Aquilano, Michele
    Cerbai, Cecilia
    Desideri, Isacco
    Ribnikar, Domen
    Marinko, Tanja
    Livi, Lorenzo
    Meattini, Icro
    CLINICAL BREAST CANCER, 2020, 20 (06) : 495 - 502
  • [23] A Phase I Study of the Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) in Patients with Advanced Solid Tumors and Lymphomas
    Infante, Jeffrey R.
    Cassier, Philippe A.
    Gerecitano, John F.
    Witteveen, Petronella O.
    Chugh, Rashmi
    Ribrag, Vincent
    Chakraborty, Abhijit
    Matano, Alessandro
    Dobson, Jason R.
    Crystal, Adam S.
    Parasuraman, Sudha
    Shapiro, Geoffrey I.
    CLINICAL CANCER RESEARCH, 2016, 22 (23) : 5696 - 5705
  • [24] First-in-human phase 1 study of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumors
    Wang, Yong-Sheng
    Jiang, Yu
    Sun, Meili
    Liang, Xu
    Li, Huiping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma
    Schwartz, GK
    Ilson, D
    Saltz, L
    O'Reilly, E
    Tong, W
    Maslak, P
    Werner, J
    Perkins, P
    Stoltz, M
    Kelsen, D
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 1985 - 1992
  • [26] The Cyclin D/Cyclin-dependent Kinase 4/6 Complex as a Target in the Treatment of Breast Cancer
    Clark A.S.
    DeMichele A.
    Current Breast Cancer Reports, 2015, 7 (4) : 175 - 182
  • [27] The Cyclin-Dependent Kinase 4/6 Inhibitor Abemaciclib Is Tolerated Better than Palbociclib by Advanced Breast Cancer Patients with High Serum Albumin Levels
    Nakatsukasa, Hitomi
    Takahashi, Masaya
    Takahashi, Katsuyuki
    Takashima, Tsutomu
    Asano, Yuka
    Morisaki, Tamami
    Kashiwagi, Shinichiro
    Noda, Satoru
    Nakamura, Yasutaka
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2022, 45 (10) : 1476 - 1481
  • [28] Liver toxicity associated to novel cyclin-dependent kinase inhibitor ribociclib in a cohort of advanced breast cancer patients
    Scaravaglio, Miki
    Ciaccio, Antonio
    Laffusa, Alice
    Luca, Martina
    Longo, Salvatore
    Manna, Martina
    Maggioni, Claudia
    Riva, Francesca
    Cicchiello, Federica
    Cazzaniga, Marina Elena
    Cortinovis, Diego
    Invernizzi, Pietro
    JOURNAL OF HEPATOLOGY, 2022, 77 : S404 - S405
  • [29] Time to Chemotherapy for Patients With Estrogen Receptor-Positive Breast Cancer and Cyclin-Dependent Kinase 4 and 6 Inhibitor Use
    Endo, Yuka
    Yoshimura, Akiyo
    Sawaki, Masataka
    Hattori, Masaya
    Kotani, Haruru
    Kataoka, Ayumi
    Horisawa, Nanae
    Ozaki, Yuri
    Nozawa, Kazuki
    Takatsuka, Daiki
    Isogai, Ayaka
    Iwata, Hiroji
    JOURNAL OF BREAST CANCER, 2022, 25 (04) : 296 - 306
  • [30] Macrocytosis and dysplastic anemia is associated with the cyclin-dependent kinase 4/6 inhibitor palbociclib in metastatic breast cancer
    Anampa, Jesus
    Haque, Tamanna
    Murakhovskaya, Irina
    Wang, Yanhua
    Bachiashvili, Kimo
    Papazoglu, Cristian
    Pradhan, Kith
    Steidl, Ulrich G.
    Sparano, Joseph A.
    Verma, Amit
    HAEMATOLOGICA, 2018, 103 (03) : E98 - E102
12345